H

Hanall Biopharma Co Ltd
KRX:009420

Watchlist Manager
Hanall Biopharma Co Ltd
KRX:009420
Watchlist
Price: 43 750 KRW -0.57% Market Closed
Market Cap: 2.3T KRW

Wall Street
Price Targets

Price Targets Summary
Hanall Biopharma Co Ltd

Wall Street analysts forecast Hanall Biopharma Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hanall Biopharma Co Ltd is 44 734.29 KRW with a low forecast of 40 400 KRW and a high forecast of 52 500 KRW.

Lowest
Price Target
40 400 KRW
8% Downside
Average
Price Target
44 734.29 KRW
2% Upside
Highest
Price Target
52 500 KRW
20% Upside
Hanall Biopharma Co Ltd Competitors:
Price Targets
CRON
Cronos Group Inc
40% Upside
RPRX
Royalty Pharma PLC
19% Upside
4502
Takeda Pharmaceutical Co Ltd
6% Upside
033270
Korea United Pharm Inc
55% Upside
AETHER
Aether Industries Ltd
27% Upside
CPH
Cipher Pharmaceuticals Inc
23% Upside
SLGL
Sol Gel Technologies Ltd
15% Upside
IPCALAB
IPCA Laboratories Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Hanall Biopharma Co Ltd

For the last 13 years the compound annual growth rate for Hanall Biopharma Co Ltd's revenue is 4%. The projected CAGR for the next 3 years is 13%.

4%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hanall Biopharma Co Ltd

The compound annual growth rate of Hanall Biopharma Co Ltd's operating income for the next 3 years is 285%.

N/A
Past Growth
285%
Estimated Growth
Estimates Accuracy
-33%
Average Miss

Net Income
Forecast

Net Income Estimate
Hanall Biopharma Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hanall Biopharma Co Ltd's stock price target?
Price Target
44 734.29 KRW

According to Wall Street analysts, the average 1-year price target for Hanall Biopharma Co Ltd is 44 734.29 KRW with a low forecast of 40 400 KRW and a high forecast of 52 500 KRW.

What is Hanall Biopharma Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for Hanall Biopharma Co Ltd's revenue is 4%. The projected CAGR for the next 3 years is 13%.

What is Hanall Biopharma Co Ltd's Operating Income forecast?
Projected CAGR
285%

The compound annual growth rate of Hanall Biopharma Co Ltd's operating income for the next 3 years is 285%.

Back to Top